Skip to main content

Table 1 Clinical baseline characteristics

From: Influences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients

Characteristics

Total (n = 732)

Group A (n = 628)

Group B (n = 104)

P

Age, mean ± SD

66.17 ± 13.19

65.81 ± 13.14

68.34 ± 13.34

0.070

  < 50

78 (10.7)

69 (11.0)

9 (8.7)

0.697

 50–70

368 (50.3)

322 (51.3)

46 (44.2)

0.561

  > 70

286 (39.0)

237 (37.7)

49 (47.1)

0.661

Female/Male [n (%)]X

253/479 (34.6/65.4)

211/417 (33.6/66.4)

42/62 (40.4/59.6)

0.178

HBP, no/yes [n (%)]

218/514 (29.8/70.2)

190/438 (30.3/69.7)

28/76 (26.9/73.1)

0.491

DM, no/yes [n (%)]H

487/245 (66.5/33.5)

424/204 (67.5/32.5)

63/41 (60.6/39.4)

0.165

Hlip, no/yes [n (%)]H

584/148 (79.8/20.2)

496/132 (79.0/21.0)

88/16 (84.6/15.4)

0.185

AF, no/yes [n (%)]H

604/128 (82.5/17.5)

541/ 87 (86.1/13.9)

63/41 (60.6/39.4)

< 0.001

SBP (mmHg)

150.35 ± 23.26

150.54 ± 23.45

149.20 ± 22.14

0.586

DBP (mmHg)

84.71 ± 13.49

84.83 ± 13.73

83.98 ± 12.00

0.550

NIHSS

7.05 ± 6.27

6.50 ± 6.10

10.39 ± 6.25

< 0.001

Hypoproteinemia, no/yes [n (%)]H

638/94 (87.2/12.8)

550/78 (87.6/12.4)

88/16(84.6/15.4)

0.403

Glucose (mmol/L)

7.33 ± 3.63

7.19 ± 3.57

8.16 ± 3.87

0.011

TC (mmol/L)

4.36 ± 1.05

4.39 ± 1.04

4.15 ± 1.08

0.035

  < 3.10

77 (10.5)

58 (9.3)

19 (18.3)

0.857

 3.10–5.70

578 (79.0)

507 (80.7)

71 (68.2)

0.047

  > 5.70

77 (10.5)

63 (10.0)

14 (13.5)

0.038

TG (mmol/L)

1.41 ± 0.87

1.44 ± 0.90

1.24 ± 0.70

0.030

  < 0.57

47 (6.4)

40 (6.4)

7 (6.7)

0.999

 0.57–1.7

514 (70.2)

435 (69.2)

79 (76.0)

0.044

  > 1.7

171 (23.4)

153 (24.4)

18 (17.3)

0.417

HDL-C (mmol/L)

1.16 ± 0.33

1.15 ± 0.33

1.21 ± 0.32

0.074

  < 0.83H

102 (13.9)

92 (14.6)

10 (9.6)

0.192

 0.83–1.96H

614 (83.9)

523 (83.3)

91 (87.5)

0.184

  > 1.96H

16 (2.2)

13 (2.1)

3 (2.9)

0.106

LDL-C (mmol/L)

2.83 ± 0.94

2.86 ± 0.92

2.67 ± 1.01

0.056

  < 2.07

152 (20.8)

124 (19.7)

28 (26.9)

0.001

 2.07–3.1

330 (45.0)

285 (45.4)

45 (43.3)

0.443

  > 3.1

250 (34.2)

219 (34.9)

31 (29.8)

0.761

  1. (X). P values were calculated by one-way ANOVA, Pearson’s Chi-square test; (H). P values were calculated by the Kruskal-Wallis H (H) test; HT Hemorrhagic transformation postacute cerebral infarction; HBP: History of hypertension; DM: Diabetes mellitus; Hlip Hyperlipidemia; SBP Systolic pressure; DBP Diastolic pressure; NIHSS National Institutes of Health Stroke Scale; TC Total cholesterol; TG Triglyceride; HDL-C High-density lipoprotein cholesterol; LDL-C Low-density lipoprotein cholesterol